TLDR
- Reports disagree on whether ARK bought or sold 348,406 SpaceX shares on November 4.
- ARK sold 15,750 Amazon shares worth $4.2 million.
- ARK also sold Alphabet and Eli Lilly shares.
- ARK bought 350,410 Nurix Therapeutics shares for about $9 million.
- ARK added Twist Bioscience, GeneDx and Pacific Biosciences shares.
Cathie Wood’s ARK Invest published its daily trades for Wednesday, November 4, 2026. The list covered technology, space and biotech holdings.
Two reports on the day’s largest trade do not agree. Both say 348,406 SpaceX shares were involved, but one says ARK sold them and the other says ARK bought them.
Space Exploration Technologies Corp., SPCX
Two Accounts of the SpaceX Trade
The first report says ARK sold the shares across its ARKK, ARKQ and ARKW funds. It puts the value at $49.2 million and calls it a large cut to ARK’s position.
The second report says ARK bought the shares and values them at $47.3 million. It notes that SpaceX had fallen about 21% from its early October high.
Cathie Wood and Ark Invest just bought 348,406 shares of SpaceX $SPCX stock today https://t.co/9tjMtE3NzE pic.twitter.com/hJLmiFJpiE
— Evan (@StockMKTNewz) November 5, 2026
SpaceX shares dropped 3.8% on Wednesday. The decline followed the midterm elections, as investors weighed what Elon Musk’s Republican connections could mean for the company.
SpaceX reported third-quarter revenue of $14.6 billion, up 161% from a year earlier. Net income came in at $4.4 billion.
Capital spending in the quarter was $19.6 billion. The company expects to spend another $35 billion to $40 billion in the fourth quarter.
On Wednesday, SpaceX announced a multiyear agreement with Qualcomm. The two will build ground infrastructure for Starlink Mobile, with a nationwide 5G rollout expected to begin in 2027.
Analysts rate SpaceX a Strong Buy, with 29 Buys, 5 Holds and one Sell. The average 12-month price target is $250.34, about 84% above current levels.
Amazon, Alphabet and Biotech Trades
ARK sold 15,750 Amazon shares worth $4.2 million. Amazon stock rose 6% on Wednesday after Democratic election wins raised the chance of tighter rules on data-center construction.
Amazon Web Services revenue rose 39% from a year earlier to $46 billion. The company plans capital spending of $220 billion this year.
ARK also sold 46,164 Alphabet shares for $12.8 million through its ARKK and ARKQ funds. It sold 8,551 Eli Lilly shares worth $12.1 million through ARKK.
ARK bought 350,410 Nurix Therapeutics shares for $9.0 million through its ARKG fund. Market data listed with one report showed Nurix shares down 38.23% on the day.
ARK added 12,943 Twist Bioscience shares worth $1.8 million through ARKK. It also bought 25,758 GeneDx Holdings shares valued at $1.8 million through ARKG.
ARK bought 73,281 Pacific Biosciences shares across ARKK and ARKG. It also sold Personalis shares through ARKG for about $6.0 million.
Analysts rate Amazon a Strong Buy, with 43 Buys and one Hold. The average 12-month price target is $324.88, about 22% above current levels.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
